When antibiotics stop working: the hidden crisis in plain sight

Around 5 million deaths per year are linked to antimicrobial resistance (AMR). And yet, the global pipeline of new antibiotics is critically underdeveloped. So how do we address the problem? 
 
Grace Hampson is joined by Lotte Steuten, Deputy CEO of the Office of Health Economics and David McKinney, Co-founder of ARMoR, to dig into the market failures surrounding the AMR crisis and what it would take to turn the tide.

They’ll discuss:
🔹Why the antibiotic pipeline is failing
🔹Push and pull incentives — including the UK's pioneering subscription model — and what makes them effective
🔹The underappreciated role of diagnostics in tackling drug-resistant infections
🔹What global coordinated action on AMR could look like  
 
A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. To enjoy future episodes, be sure to subscribe to A Dose of Economics’ dedicated YouTube channel @OHENews

If there’s a topic you’d like us to cover, feel free to ⁠⁠share your ideas⁠⁠ in the comment section.